Cite
An in vitro study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia.
MLA
Sadick, Haneen, et al. “An in Vitro Study on the Effect of Bevacizumab on Endothelial Cell Proliferation and VEGF Concentration Level in Patients with Hereditary Hemorrhagic Telangiectasia.” Experimental & Therapeutic Medicine, vol. 24, no. 3, Sept. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3892/etm.2022.11493.
APA
Sadick, H., Schäfer, E., Weiss, C., Rotter, N., Müller, C. E., Birk, R., Sadick, M., & Häussler, D. (2022). An in vitro study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia. Experimental & Therapeutic Medicine, 24(3), N.PAG. https://doi.org/10.3892/etm.2022.11493
Chicago
Sadick, Haneen, Elena Schäfer, Christel Weiss, Nicole Rotter, Cornelia Emika Müller, Richard Birk, Maliha Sadick, and Daniel Häussler. 2022. “An in Vitro Study on the Effect of Bevacizumab on Endothelial Cell Proliferation and VEGF Concentration Level in Patients with Hereditary Hemorrhagic Telangiectasia.” Experimental & Therapeutic Medicine 24 (3): N.PAG. doi:10.3892/etm.2022.11493.